Heparin

On February 14, 2008, Zoll, Kranz & Borgess, LLC was the first law firm in the nation to file suit against Baxter Healthcare Corporation and other related companies regarding contaminated batches of its drug, Heparin. We are continuing to lead the way with multiple cases filed in federal court and have ongoing investigations into possible cases both in and outside Ohio. 

Recently, our law firm was honored when three of our clients, Leroy Hubley, Colleen Hubley and Johanna Staples, were invited by the U.S. House Commerce Committee on Energy and Commerce (one of the oldest standing committees of the U.S. House of Representatives) to speak on April 29, 2008, at a hearing entitled, “The Heparin Disaster: Chinese Counterfeits and American Failures.” 

Video of each panel of the hearing is available on the links below:

Panel I (Witnesses: David Nelson, Senior Investigator for the Committee on Energy and Commerce, Colleen Hubley, Leroy Hubley, and Johanna Marie Staples)

Panel II (Witnesses: Janet Woodcock, Director of the FDA’s Center for Drug Evaluation and Research, Deborah M. Autor, Director of FDA’s Office of Compliance, and Regina T. Brown, Consumer Safter Officer of the FDA’s Division of Field Investigations)

Panels III and IV (Witnesses: Robert Parkinson, CEO and President of Baxter International, Inc., David Strunce, CEO of Scientific Protein Laboratories, Yan Wang, Ph.D., Vice President of Business Development and Research at Scientific Protein Laboratories, and Clive Meanwell, CEO of The Medicines Co.)

In addition, to view the written statements submitted by Leroy Hubley, Colleen Hubley Johanna Staples, and other witnesses please click on their name below:

• Leroy Hubley 

• Colleen Hubley 

• Johanna Staples

• David Nelson, Senior Investigator for the Committee on Energy and Commerce

• Janet Woodcock, Director of the FDA’s Center for Drug Evaluation

• Robert Parkinson, CEO and President of Baxter International, Inc.  

• David Strunce, CEO of Scientific Protein Laboratories

• Clive Meanwell, CEO of The Medicines Co.

Additional information regarding the recall of contaminated heparin and subsequent litigation can be obtained by clicking on the links below:

• What is Heparin?

• Overview of the Heparin Recall and the Contaminant

• Allegations in the Lawsuits Filed by Zoll, Kranz & Borgess, LLC

• Media Reports and Related News Articles and Links

Please contact our law office by phone at 419-841-9623 or by email at pamela@toledolaw.com if you or someone close to you may have been given heparin during dialysis or during any other procedure, and experienced any of the following symptoms or death:

• Oral swelling

• Abdominal pain 

• Burning sensation

• Chest pain

• Diarrhea

• Dizziness 

• Drug ineffectiveness

• Painful, difficult, or disturbed digestion

• Dyspnea [unpleasant or uncomfortable breathing]

• Erythema [redness of the skin] 

• Flushing 

• Headache 

• Hyperhidrosis [excessive sweating] 

• Hypoesthesia [reduced sense of touch or sensation] 

• Increased lacrimation [production, secretion, and shedding of tears] 

• Loss of consciousness

• Malaise [general discomfort or uneasiness]

• Nausea 

• Pallor 

• Palpitations

• Paresthesia [tingling, pricking, or numbness of a person's skin]

• Pharyngeal edema [swelling in throat] 

• Restlessness 

• Vomiting/retching 

• Shortness of breath

• Stomach discomfort

• Tachycardia [rapid beating of the heart]

• Thirst

• Trismus [Inability to open the mouth fully] 

• Unresponsiveness to stimuli

• Severe hypotension [abnormally low blood pressure] 

The call is free and there is no obligation.